Document text
From: Patel, Amit
To: Okoye, Christopher
Cc: Austin-Hansberry, Lori
Subject: [EXTERNAL] RE: FDA Waiver - COMIRNATY
Date: Wednesday, September 29, 2021 5:04:08 PM
Attachments: image001.png
CAUTION: This email originated from outside of the organization. Do not click links or open attachments unless you
recognize the sender and know the content is safe.
Hi Christopher, I confirm receipt.
Thanks
Amit
From: Okoye, Christopher <[email protected]>
Sent: Wednesday, September 29, 2021 3:58 PM
To: Patel, Amit <[email protected]>
Cc: Austin-Hansberry, Lori <[email protected]>
Subject: [EXTERNAL] FDA Waiver - COMIRNATY
Dear Amit Patel:
Attached is the FDA Waiver Response Letter for COMIRNATY, STN 125742/0.
This letter is the official copy for your records. This email will not be followed with a
paper copy.
Please confirm receipt of this message.
Thank you,
Christopher Okoye, PharmD
LT, U.S. Public Health Service
Regulatory Project Manager, Division of Epidemiology
Center for Biologics Evaluation and Research
Office of Biostatistics and Epidemiology
U.S. Food and Drug Administration
Tel: (240) 402-6996
[email protected]
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED AND MAY
FDA-CBER-2021-5683-1072436
CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE
UNDER LAW. If you are not the addressee, or a person authorized to deliver the document to the addressee, you
are hereby notified that any review, disclosure, dissemination, copying, or other action based on the content of this
communication is not authorized. If you have received this document in error, please immediately notify the sender
by e-mail or phone.
FDA-CBER-2021-5683-1072437